US Pharmaceutical Excipients Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on US Pharmaceutical Excipients Market 

5.1. COVID-19 Landscape: US Pharmaceutical Excipients Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact:  Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. US Pharmaceutical Excipients Market, By Functionality

8.1. US Pharmaceutical Excipients Market, by Functionality

8.1.1. Fillers and Diluents

8.1.1.1. Market Revenue and Forecast

8.1.2. Suspending and Viscosity Agents

8.1.2.1. Market Revenue and Forecast

8.1.3. Coating Agents

8.1.3.1. Market Revenue and Forecast

8.1.4. Binders

8.1.4.1. Market Revenue and Forecast

8.1.5. Disintegrants

8.1.5.1. Market Revenue and Forecast

8.1.6. Colorants

8.1.6.1. Market Revenue and Forecast

8.1.7. Lubricants and Glidants

8.1.7.1. Market Revenue and Forecast

8.1.8. Preservatives

8.1.8.1. Market Revenue and Forecast

8.1.9. Emulsifying Agents

8.1.9.1. Market Revenue and Forecast

8.1.10. Flavoring Agents and Sweeteners

8.1.10.1. Market Revenue and Forecast

8.1.11. Other Functionalities

8.1.12.1. Market Revenue and Forecast

Chapter 9. US Pharmaceutical Excipients Market, By Excipient Type

9.1. US Pharmaceutical Excipients Market, by Excipient Type

9.1.1. Lactose-based Excipients

9.1.1.1. Market Revenue and Forecast

9.1.2. Cellulose-based

9.1.2.1. Market Revenue and Forecast

9.1.3. Starches

9.1.3.1. Market Revenue and Forecast

9.1.4. Carboxymethylcellulose Sodium (CCS)

9.1.4.1. Market Revenue and Forecast

9.1.5. Sodium Starch Glycolate (SSG)

9.1.5.1. Market Revenue and Forecast

9.1.6. Fine Chemicals

9.1.6.1. Market Revenue and Forecast

9.1.7. Mannitol

9.1.7.1. Market Revenue and Forecast

9.1.8. Biopharma Excipients

9.1.8.1. Market Revenue and Forecast

9.1.9. Others

9.1.9.1. Market Revenue and Forecast

Chapter 10. US Pharmaceutical Excipients Market, Regional Estimates and Trend Forecast

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Functionality

10.1.3.2. Market Revenue and Forecast, by Excipient Type

Chapter 11. Company Profiles

11.1. BASF SE

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Ashland Global Holdings Inc.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. DuPont de Nemours Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Roquette Frères SA

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Evonik Industries AG

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Archer Daniels Midland Co.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Kerry Group plc

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. The Lubrizol Corporation

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Air Liquide SA

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Croda International plc

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms